• Accueil
• cg-1
• CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range

CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range

4.7 (563) · € 31.50 · En Stock

CG Oncology Is Late Stage Looker For Life Science Investors (Pending:CGON)

Instacart's $660 Million IPO Meets Goal with $30 a Share Pricing - Bloomberg

CG Oncology Goes Public @$19 per Share, Targeting $10B Bladder Cancer Market—Lots of Risks

CG Oncology IPO Soars 96% on Day 1 - Orange County Business Journal

Temasek-Backed UST Seeks to Raise at Least $500 Million in IPO - Bloomberg

Deal Point Data - Merger Agreements, Corporate Governance, IPOs, High Yield Debt Covenants, Spin Offs

IPO Rebound in the US Fuels 2024 Optimism From Paris to Tokyo - Bloomberg

424B4

Earnings call: Alexandria Real Estate Equities posts solid 2023 results - Investing.com ZA

Biotech, Pharmaceutical and Clinical Research News

Reddit Advised to Target at Least $5 Billion Value in IPO - Bloomberg

Bladder cancer biotech CG Oncology raises $380 million in IPO

Biotech CG Oncology Soars 96% in Debut After Expanded IPO - Bloomberg

CG Oncology Sets IPO Target, Looks to Raise Up to $209M